Published in Immunology on November 01, 1999
CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. J Clin Invest (2003) 1.15
Hyaluronan anchored to activated CD44 on central nervous system vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitis. J Biol Chem (2012) 0.87
IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS during chronic infection. J Neuroimmunol (2008) 0.80
Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS. J Biol Chem (2014) 0.79
Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A (2016) 0.78
Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: implications for inflammatory demyelinating disease. Matrix Biol (2013) 0.78
Streptococcal cell wall induced arthritis: leukocyte activation in extra-articular lymphoid tissue. Inflammation (2003) 0.75
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 27.85
A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature (1983) 8.20
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science (1989) 5.61
Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol (1987) 5.07
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med (1993) 4.99
Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (1996) 3.84
Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol (1987) 3.84
Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics (1982) 3.18
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91
A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell (1995) 2.89
Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol (1991) 2.69
CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med (1996) 2.37
Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med (1995) 2.05
Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A (1999) 1.98
CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med (1993) 1.91
Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol (1995) 1.76
Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol (1992) 1.76
Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today (1995) 1.72
Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol (1990) 1.58
Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol (1990) 1.51
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum (1991) 1.35
Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. Immunology (1995) 1.30
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology (1993) 1.30
Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J Immunol (1994) 1.27
Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. J Immunol (1995) 1.25
A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol (1995) 1.20
Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J Immunol (1994) 1.14
Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RB(low) CD4+ T cells that induce experimental allergic encephalomyelitis. J Neuroimmunol (1992) 1.13
Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum (1999) 1.11
Lymphocyte migration into tissue: the paradigm derived from CD4 subsets. Curr Opin Immunol (1996) 1.09
Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell Immunol (1993) 1.04
Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int Immunol (1995) 1.02
Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol (1995) 1.01
Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J Neuroimmunol (1994) 0.99
Lymphocyte migration into the CNS modelled in vitro: roles of LFA-1, ICAM-1 and VLA-4. Immunology (1994) 0.94
Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules. Immunogenetics (1993) 0.93
Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult Scler (1998) 0.91
Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice. J Neurol Sci (1991) 0.90
Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett (1994) 0.90
CD44 expression by leucocytes in rheumatoid arthritis and modulation by specific antibody: implications for lymphocyte adhesion to endothelial cells and synoviocytes in vitro. Scand J Immunol (1997) 0.89
Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J Immunol (1999) 0.89
Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies. J Neuroimmunol (1993) 0.89
CD44 antibody stimulates adhesion of peripheral blood T cells to keratinocytes through the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J Invest Dermatol (1993) 0.83
Presence of T cells with activated and memory phenotypes in inflammatory spinal cord lesions. J Immunol (1995) 0.83
Anti-CD44 treatment does not prevent the extravasation of autopathogenic T cells to the thyroid in experimental autoimmune thyroiditis. Immunology (1999) 0.77
The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med (1997) 12.21
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions. J Mol Biol (1997) 10.38
Contact order, transition state placement and the refolding rates of single domain proteins. J Mol Biol (1998) 8.51
Native protein sequences are close to optimal for their structures. Proc Natl Acad Sci U S A (2000) 7.99
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men. Am J Public Health (1981) 6.91
Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol (1996) 6.51
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
Consistent land- and atmosphere-based U.S. carbon sink estimates. Science (2001) 5.49
Recent patterns and mechanisms of carbon exchange by terrestrial ecosystems. Nature (2001) 5.11
Improved recognition of native-like protein structures using a combination of sequence-dependent and sequence-independent features of proteins. Proteins (1999) 4.86
Job strain and cardiovascular disease. Annu Rev Public Health (1994) 4.59
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins (1999) 3.79
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob Agents Chemother (2000) 3.54
Experiment and theory highlight role of native state topology in SH3 folding. Nat Struct Biol (1999) 3.50
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Research priorities. Shining light into black boxes. Science (2012) 3.06
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol (2001) 3.05
Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain. Nat Struct Biol (1998) 3.02
The natural history of spondylolysis and spondylolisthesis. J Bone Joint Surg Am (1984) 3.02
Clustering of low-energy conformations near the native structures of small proteins. Proc Natl Acad Sci U S A (1998) 2.92
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA (2000) 2.91
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis (2007) 2.89
Protein transport to the vacuole and receptor-mediated endocytosis by clathrin heavy chain-deficient yeast. J Cell Biol (1988) 2.86
Prediction of protein-folding mechanisms from free-energy landscapes derived from native structures. Proc Natl Acad Sci U S A (1999) 2.86
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis (2009) 2.68
Development of the AHCPR-sponsored heart failure guideline: methodologic and procedural issues. Jt Comm J Qual Improv (1994) 2.61
Prediction of local structure in proteins using a library of sequence-structure motifs. J Mol Biol (1998) 2.50
Critical role of beta-hairpin formation in protein G folding. Nat Struct Biol (2000) 2.46
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis (2008) 2.45
Prospects for ab initio protein structural genomics. J Mol Biol (2001) 2.43
Topology, stability, sequence, and length: defining the determinants of two-state protein folding kinetics. Biochemistry (2000) 2.42
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Out-patient Treatment of Early Syphilis with Penicillin. Br Med J (1946) 2.40
De novo protein structure determination using sparse NMR data. J Biomol NMR (2000) 2.37
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Role of neurogenic genes in establishment of follicle cell fate and oocyte polarity during oogenesis in Drosophila. Cell (1991) 2.33
Successful techniques for retention of study participants in an inner-city population. Control Clin Trials (1998) 2.32
Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol (1998) 2.31
HMMSTR: a hidden Markov model for local sequence-structure correlations in proteins. J Mol Biol (2000) 2.26
A breakdown of symmetry in the folding transition state of protein L. J Mol Biol (2000) 2.26
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol (1998) 2.22
Computer-based redesign of a protein folding pathway. Nat Struct Biol (2001) 2.17
Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis (1973) 2.12
Toward high-resolution prediction and design of transmembrane helical protein structures. Proc Natl Acad Sci U S A (2007) 2.12
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Functional rapidly folding proteins from simplified amino acid sequences. Nat Struct Biol (1997) 2.08
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience (2006) 2.07
Rosetta in CASP4: progress in ab initio protein structure prediction. Proteins (2001) 2.07
Ab initio protein structure prediction: progress and prospects. Annu Rev Biophys Biomol Struct (2001) 2.05
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol (1994) 2.03
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Measuring empathy: reliability and validity of the Empathy Quotient. Psychol Med (2004) 1.99
Design and methods of the National Cooperative Inner-City Asthma Study. Pediatr Pulmonol (1997) 1.95
Chain collapse can occur concomitantly with the rate-limiting step in protein folding. Nat Struct Biol (1999) 1.92
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis. Ann Rheum Dis (1967) 1.89
Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod (2008) 1.89
Kinetics of folding of the IgG binding domain of peptostreptococcal protein L. Biochemistry (1997) 1.83
Mechanisms of protein folding. Curr Opin Struct Biol (2001) 1.80
Matching theory and experiment in protein folding. Curr Opin Struct Biol (1999) 1.79
Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability. Proc Natl Acad Sci U S A (1997) 1.78
Limited internal friction in the rate-limiting step of a two-state protein folding reaction. Proc Natl Acad Sci U S A (1998) 1.74
Prediction of membrane protein structures with complex topologies using limited constraints. Proc Natl Acad Sci U S A (2009) 1.73
Folding dynamics of the src SH3 domain. Biochemistry (1997) 1.72
Molecular dynamics in the endgame of protein structure prediction. J Mol Biol (2001) 1.69
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol (1994) 1.61
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg (1996) 1.58
Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol (1999) 1.57
NMR characterization of residual structure in the denatured state of protein L. J Mol Biol (2000) 1.57
Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol (1995) 1.55
Improving the performance of Rosetta using multiple sequence alignment information and global measures of hydrophobic core formation. Proteins (2001) 1.54
A desolvation barrier to hydrophobic cluster formation may contribute to the rate-limiting step in protein folding. Protein Sci (1997) 1.52
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) (1986) 1.49
Omental transposition in chronic spinal cord injury. Spinal Cord (1996) 1.49
Oral health literacy among female caregivers: impact on oral health outcomes in early childhood. J Dent Res (2010) 1.49
Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol (2010) 1.47
Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis. J Rheumatol (1990) 1.46
The sequences of small proteins are not extensively optimized for rapid folding by natural selection. Proc Natl Acad Sci U S A (1998) 1.45
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis (2007) 1.44
Simplified proteins: minimalist solutions to the 'protein folding problem'. Curr Opin Struct Biol (1998) 1.43
An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse. Br J Ophthalmol (2001) 1.42
Contextual variations in the meaning of health inequality. Soc Sci Med (1991) 1.42
Venous air embolism in patients with pulmonary barotrauma. Crit Care Med (1994) 1.42
Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) (1980) 1.41
Laser-assisted lead extraction: the European experience. Europace (2007) 1.41
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Experimental encephalomyelitis modulates inositol and taurine in the spinal cord of Biozzi mice. Magn Reson Med (1994) 1.40
The anatomy of an OPTI: Part 2. The CORE system. Ohio Osteopathic Hospital Association. Ohio Association of Osteopathic Medical Directors. Ohio Osteopathic Association. J Am Osteopath Assoc (1997) 1.39